| Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development | |
| Grau, Michael; Gu, Juan J.; Singh, Anil; Xue, Kai; Mavis, Cory; Barth, Matthew; Hernandez-Ilizaliturri, Francisco J.; Lenz, Peter; Yanamadala, Vivek; Czuczman, Myron S. | |
| 刊名 | ONCOTARGET
 |
| 2018 | |
| 卷号 | 9期号:3 |
| 关键词 | hexokinase II rituximab-chemotherapy resistance lymphoma glucose metabolism |
| ISSN号 | 1949-2553 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3600023 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Grau, Michael,Gu, Juan J.,Singh, Anil,et al. Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development[J]. ONCOTARGET,2018,9(3). |
| APA | Grau, Michael.,Gu, Juan J..,Singh, Anil.,Xue, Kai.,Mavis, Cory.,...&Lenz, Georg.(2018).Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development.ONCOTARGET,9(3). |
| MLA | Grau, Michael,et al."Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development".ONCOTARGET 9.3(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论